Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
The Charge Transmitter alert appears once the battery reaches 10% power remaining. Once the alert appears, the smart transmitter has approximately 2 hours of power left.
It is important to charge your battery when you receive the “Charge Transmitter” alert.
The Eversense® E3 Smart Transmitter is intended to be single-patient use only. DO NOT exchange smart transmitters with another person. Each smart transmitter can be linked to only one sensor at a time.
The most recent 90 days of your glucose data is stored in the app. Uninstalling/re-installing the app will clear all the data from the mobile device and only the most recent three days’ worth of glucose data will be retrieved from the smart transmitter and stored in the app.
HI or LO will be displayed. You will also receive an Out of Range High or Low Alert.
Out of Range Low Glucose:
Appears when your glucose reading is lower than 40mg/dL.
No glucose reading can be displayed (only LO is displayed on the MY GLUCOSE screen).
Confirm your glucose value with a blood glucose meter test before making a treatment decision.
Once the sensor glucose value is at or higher than 40mg/dL, glucose readings will resume on the display.
Out of Range High Glucose:
Appears when your glucose value is higher than 400 mg/dL.
No glucose reading can be displayed (only HI is displayed on the MY GLUCOSE screen).
Measure your glucose manually by using your blood glucose meter. Always confirm your glucose value with a blood glucose meter test before making a treatment decision.
Once the sensor glucose value is at or lower than 400mg/dL, glucose readings will resume on the display.
A glucose alert warns you that a situation needs your attention and that you should respond/take appropriate action. The Eversense® E3 CGM system provides high and low glucose threshold alerts, out of range high and low glucose alerts, rate of change glucose alerts, and predictive glucose alerts.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060